{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:53:06Z","timestamp":1758815586058},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urologe [A]"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1007\/s00120-005-0769-9","type":"journal-article","created":{"date-parts":[[2005,2,11]],"date-time":"2005-02-11T14:07:35Z","timestamp":1108130855000},"page":"244-255","source":"Crossref","is-referenced-by-count":9,"title":["Medikament\ufffdse Therapie der weiblichen Harninkontinenz"],"prefix":"10.1007","volume":"44","author":[{"given":"C.","family":"Hampel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Gillitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Pahernik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. W.","family":"Melchior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. W.","family":"Th\ufffdroff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","unstructured":"Abrams P, Andersson KE, Artibani W et al. (2002) Evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence. In: Abrams P, Cardozo L, Khoury S (eds) Incontinence. 2nd International Consultation on Incontinence July 1?3, 2001, Plymbridge Health Publication Ltd., Plymouth, pp\u00a01079?1117"},{"key":"CR2","doi-asserted-by":"crossref","unstructured":"Hampel C, Th\u00fcroff JW (2004) Pharmakologie des Harntraktes. In: Palmtag H, Goepel M, Heidler H (Hrsg) Urodynamik. Springer, Berlin Heidelberg New York Tokio, S\u00a017?33","DOI":"10.1007\/978-3-662-10727-0_3"},{"key":"CR3","first-page":"314","volume":"6","author":"Pakulski","year":"2000","unstructured":"Pakulski C, Drobnik L, Millo B (2000) Age and sex as factors modifying the function of the blood-cerebrospinal fluid barrier. Med Sci Monit 6 (2): 314?318","journal-title":"Med Sci Monit"},{"key":"CR4","first-page":"50","volume":"A","author":"Hampel","year":"2003","unstructured":"Hampel C, Pahernik S, Gillitzer R, Hohenfellner M, Th\u00fcroff JW (2003) Erste klinische Erfahrungen mit der disseminierten Botulinumtoxin A-Detrusorinjektion bei nicht neurogener therapierefrakt\u00e4rer Blasenhyperaktivit\u00e4t. Urologe A [Suppl 1]: 50","journal-title":"Urologe"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","volume":"164","author":"Schurch","year":"2000","unstructured":"Schurch B, Stohrer M, Kramer G, Schmid DM, Gaul G, Hauri D (2000) Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 164 (3): 692?697","journal-title":"J Urol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM200003023420918","volume":"342","author":"Schurch","year":"2000","unstructured":"Schurch B, Schmid DM, Stohrer M (2000) Treatment of neurogenic incontinence with botulinum toxin A. N Engl J Med 342 (9): 665","journal-title":"N Engl J Med"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00120-004-0573-y","volume":"43","author":"Hampel","year":"2004","unstructured":"Hampel C, Gillitzer R, Pahernik S, Melchior SW, Thuroff JW (2004) Ver\u00e4nderungen des Rezeptorprofils der alternden Blase. Urologe A 43 (5): 535?541","journal-title":"Urologe A"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1471-0528.1984.tb04767.x","volume":"91","author":"Gr\u00fcneberger","year":"1984","unstructured":"Gr\u00fcneberger A (1984) Treatment of motor urge incontinence with clenbuterol and flavoxate hydrochloride. Br J Obstet Gynaecol 91 (3): 275?278","journal-title":"Br J Obstet Gynaecol"},{"key":"CR9","doi-asserted-by":"crossref","unstructured":"Moehrer B, Hextall A, Jackson S (2003) Oestrogens for urinary incontinence in women (Cochrane Methodology Review). The Cochrane Library 4","DOI":"10.1002\/14651858.CD001405"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00005392-199907000-00002","volume":"162","author":"Chancellor","year":"1999","unstructured":"Chancellor MB, de Groat WC (1999) Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder. J Urol 162 (1): 3?11","journal-title":"J Urol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0022-5347(05)64683-6","volume":"168","author":"Silva","year":"2002","unstructured":"Silva C, Ribeiro MJ, Cruz F (2002) The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input. J Urol 168 (2): 575?579","journal-title":"J Urol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s003450100221","volume":"19","author":"Truss","year":"2001","unstructured":"Truss MC, Stief CG, Uckert S et al. (2001) Phosphodiesterase 1 inhibition in the treatment of lower urinary tract dysfunction: from bench to bedside. World J Urol 19 (5): 344?350","journal-title":"World J Urol"},{"key":"CR13","first-page":"1014","volume":"274","author":"Thor","year":"1995","unstructured":"Thor KB, Katofiasc MA (1995) Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat. J Pharmacol Exp Ther 274 (2): 1014?1024","journal-title":"J Pharmacol Exp Ther"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0006-8993(79)90370-6","volume":"169","author":"McCall","year":"1979","unstructured":"McCall RB, Aghajanian GK (1979) Serotonergic facilitation of facial motoneuron excitation. Brain Res 169 (1): 11?27","journal-title":"Brain Res"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/01.ju.0000080708.87092.cc","volume":"170","author":"Dmochowski","year":"2003","unstructured":"Dmochowski RR, Miklos JR, Norton PA, Zinner NR, Yalcin I, Bump RC (2003) Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence. J Urol 170 (4): 1259?1263","journal-title":"J Urol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0022-5347(18)38464-7","volume":"171","author":"Ghoniem","year":"2004","unstructured":"Ghoniem GM, Elser DM, Freeman R et al. (2004) Controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment, and no treatment in women with stress urinary incontinence (SUI). J Urol 171 [Suppl 4]: 326","journal-title":"J Urol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2165\/00003495-198835040-00006","volume":"35","author":"Andersson","year":"1988","unstructured":"Andersson KE (1988) Current concepts in the treatment of disorders of micturition. Drugs 35 (4): 477?494","journal-title":"Drugs"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000052327","volume":"36","author":"Sullivan","year":"1999","unstructured":"Sullivan J, Abrams P (1999) Pharmacological management of incontinence. Eur Urol 36 [Suppl 1]: 89?95","journal-title":"Eur Urol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0022-5347(01)66376-6","volume":"155","author":"Schurch","year":"1996","unstructured":"Schurch B, Hauri D, Rodic B, Curt A, Meyer M, Rossier AB (1996) Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol 155 (3): 1023?1029","journal-title":"J Urol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1474-4422(03)00622-7","volume":"3","author":"Andersson","year":"2004","unstructured":"Andersson KE (2004) Antimuscarinics for treatment of overactive bladder. Lancet Neurol 3 (1): 46?53","journal-title":"Lancet Neurol"},{"key":"CR21","unstructured":"Napier C, Gupta P (2002) Darifenacin is selective for the human recombinant M3 receptor subtype. ICS, Heidelberg"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00210-002-0554-x","volume":"366","author":"Ikeda","year":"2002","unstructured":"Ikeda K, Kobayashi S, Suzuki M et al. (2002) M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland. Naunyn Schmiedebergs Arch Pharmacol 366 (2): 97?103","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0090-4295(03)00755-6","volume":"62","author":"Hunskaar","year":"2003","unstructured":"Hunskaar S, Burgio K, Diokno A, Herzog AR, Hjalmas K, Lapitan MC (2003) Epidemiology and natural history of urinary incontinence in women. Urology 62 [4 Suppl 1]: 16?23","journal-title":"Urology"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0165-6147(00)01737-5","volume":"22","author":"Eglen","year":"2001","unstructured":"Eglen RM, Choppin A, Watson N (2001) Therapeutic opportunities from muscarinic receptor research. Trends Pharmacol Sci 22 (8): 409?414","journal-title":"Trends Pharmacol Sci"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1021\/jm990607u","volume":"43","author":"Felder","year":"2000","unstructured":"Felder CC, Bymaster FP, Ward J, DeLapp N (2000) Therapeutic opportunities for muscarinic receptors in the central nervous system. J Med Chem 43 (23): 4333?4353","journal-title":"J Med Chem"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1046\/j.1442-2042.2002.00548.x","volume":"9","author":"Nakamura","year":"2002","unstructured":"Nakamura T, Kimura J, Yamaguchi O (2002) Muscarinic M2 receptors inhibit Ca2+-activated K+ channels in rat bladder smooth muscle. Int J Urol 9 (12): 689?696","journal-title":"Int J Urol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00120-004-0573-y","volume":"43","author":"Hampel","year":"2004","unstructured":"Hampel C, Albrecht D, O?Connell M, Anderson R, Preik M (2004) Bedeutung einer osmotisch kontrollierten Freisetzung von Oxybutynin f\u00fcr die Schweregrad-abh\u00e4ngige Therapie des Blasen\u00fcberaktivit\u00e4tssyndroms. Urologe A 43 [Suppl 1]: 52","journal-title":"Urologe A"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0090-4295(00)01020-7","volume":"56","author":"Dmochowski","year":"2000","unstructured":"Dmochowski RR, Appell RA (2000) Advancements in pharmacologic management of the overactive bladder. Urology 56 [6 Suppl 1]: 41?49","journal-title":"Urology"},{"key":"CR29","unstructured":"Wellh\u00f6ner H-H (1997) Pharmakologie und Toxikologie. Springer, Berlin Heidelberg New York, S\u00a0571"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1464-410X.2000.00061.x","volume":"85","author":"Schwinn","year":"2000","unstructured":"Schwinn DA, Michelotti GA (2000) Alpha-1-adrenergic receptors in the lower urinary tract and vascular bed: potential role for the alpha1d subtype in filling symptoms and effects of ageing on vascular expression. Br J Urol Int 85 [Suppl 2]: 6?11","journal-title":"Br J Urol Int"}],"container-title":["Der Urologe, Ausgabe A"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-005-0769-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-005-0769-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-005-0769-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T19:23:10Z","timestamp":1586114590000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-005-0769-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["769"],"URL":"https:\/\/doi.org\/10.1007\/s00120-005-0769-9","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}